XML 14 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 168,027 $ 523,506
Marketable securities 686,761 669,116
Accounts receivable ($0 and $0.3 million, respectively, from related party) 6,491 3,768
Prepaid expenses and other current assets 32,214 20,407
Total current assets 893,493 1,216,797
Marketable securities - noncurrent 137,752 69,338
Property and equipment, net 33,800 27,921
Operating lease right-of-use assets 118,775 133,076
Equity method investment 17,166 32,455
Investments and other assets 42,363 40,527
Total Assets 1,243,349 1,520,114
Current Liabilities:    
Accounts payable 3,553 5,154
Accrued expenses ($1.0 million and $1.6 million, respectively, from related party) 57,979 60,876
Current portion of operating lease liability 17,074 16,685
Current portion of deferred revenue ($0 and $19.9 million, respectively, from related party) 13,347 43,839
Total current liabilities 91,953 126,554
Deferred revenue, net of current portion 12,719 19,932
Long-term operating lease liability 101,263 114,018
Contingent consideration liability 0 24,026
Total liabilities 205,935 284,530
Commitments and contingencies (Note 6)
Stockholders’ Equity:    
Common stock, $0.0001 par value; 240,000,000 and 120,000,000 shares authorized at September 30, 2023 and December 31, 2022, respectively; 89,097,821 and 87,103,007 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively 9 9
Additional paid-in capital 2,567,195 2,420,223
Accumulated other comprehensive loss (3,572) (7,461)
Accumulated deficit (1,526,218) (1,177,187)
Total stockholders’ equity 1,037,414 1,235,584
Total Liabilities and Stockholders’ Equity $ 1,243,349 $ 1,520,114